A citation-based method for searching scientific literature

H D Rosas, W J Koroshetz, Y I Chen, C Skeuse, M Vangel, M E Cudkowicz, K Caplan, K Marek, L J Seidman, N Makris, B G Jenkins, J M Goldstein. Neurology 2003
Times Cited: 366







List of co-cited articles
1537 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
39

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
28

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
28

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
20

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson,[...]. Lancet Neurol 2013
479
19

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, Raymund Ac Roos, Alexandra Durr, David Craufurd, Christopher Kennard, Stephen L Hicks, Nick C Fox, Rachael I Scahill,[...]. Lancet Neurol 2009
633
19

Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
H Diana Rosas, David S Tuch, Nathanael D Hevelone, Alexandra K Zaleta, Mark Vangel, Steven M Hersch, David H Salat. Mov Disord 2006
242
19

Differential loss of striatal projection neurons in Huntington disease.
A Reiner, R L Albin, K D Anderson, C J D'Amato, J B Penney, A B Young. Proc Natl Acad Sci U S A 1988
726
17

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Sarah J Tabrizi, Rachael I Scahill, Alexandra Durr, Raymund Ac Roos, Blair R Leavitt, Rebecca Jones, G Bernhard Landwehrmeyer, Nick C Fox, Hans Johnson, Stephen L Hicks,[...]. Lancet Neurol 2011
381
16

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
569
15

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
895
15

Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
526
15

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Sarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, Alexandra Durr, Blair Leavitt, Gail Owen, Rebecca Jones, Hans Johnson, David Craufurd, Stephen L Hicks,[...]. Lancet Neurol 2012
353
15


Huntington's disease.
Francis O Walker. Lancet 2007
14

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
533
14

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
C Zuccato, A Ciammola, D Rigamonti, B R Leavitt, D Goffredo, L Conti, M E MacDonald, R M Friedlander, V Silani, M R Hayden,[...]. Science 2001
921
13

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.
H Diana Rosas, David H Salat, Stephanie Y Lee, Alexandra K Zaleta, Vasanth Pappu, Bruce Fischl, Doug Greve, Nathanael Hevelone, Steven M Hersch. Brain 2008
316
13

Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
G Douaud, V Gaura, M-J Ribeiro, F Lethimonnier, R Maroy, C Verny, P Krystkowiak, P Damier, A-C Bachoud-Levi, P Hantraye,[...]. Neuroimage 2006
184
13

Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.
H D Rosas, N D Hevelone, A K Zaleta, D N Greve, D H Salat, B Fischl. Neurology 2005
228
13

Longitudinal change in regional brain volumes in prodromal Huntington disease.
Elizabeth H Aylward, Peggy C Nopoulos, Christopher A Ross, Douglas R Langbehn, Ronald K Pierson, James A Mills, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Jane S Paulsen. J Neurol Neurosurg Psychiatry 2011
162
13

Early atrophy of pallidum and accumbens nucleus in Huntington's disease.
Simon J A van den Bogaard, Eve M Dumas, Tanka P Acharya, Hans Johnson, Douglas R Langbehn, Rachael I Scahill, Sarah J Tabrizi, Mark A van Buchem, Jeroen van der Grond, Raymund A C Roos. J Neurol 2011
81
16

Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
558
13

Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection.
E Spargo, I P Everall, P L Lantos. J Neurol Neurosurg Psychiatry 1993
111
12

Striatal and white matter predictors of estimated diagnosis for Huntington disease.
Jane S Paulsen, Peggy C Nopoulos, Elizabeth Aylward, Christopher A Ross, Hans Johnson, Vincent A Magnotta, Andrew Juhl, Ronald K Pierson, James Mills, Douglas Langbehn,[...]. Brain Res Bull 2010
165
12

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
423
12

Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection".
H Diana Rosas, Stephanie Y Lee, Alexander C Bender, Alexandra K Zaleta, Mark Vangel, Peng Yu, Bruce Fischl, Vasanth Pappu, Christina Onorato, Jang-Ho Cha,[...]. Neuroimage 2010
178
12

Regional and progressive thinning of the cortical ribbon in Huntington's disease.
H D Rosas, A K Liu, S Hersch, M Glessner, R J Ferrante, D H Salat, A van der Kouwe, B G Jenkins, A M Dale, B Fischl. Neurology 2002
771
12

Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.
Damian M Cummings, Véronique M André, Besim O Uzgil, Steven M Gee, Yvette E Fisher, Carlos Cepeda, Michael S Levine. J Neurosci 2009
118
11

Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
L A Raymond, V M André, C Cepeda, C M Gladding, A J Milnerwood, M S Levine. Neuroscience 2011
191
11

Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
Taneli Heikkinen, Kimmo Lehtimäki, Nina Vartiainen, Jukka Puoliväli, Susan J Hendricks, Jack R Glaser, Amyaouch Bradaia, Kristian Wadel, Chrystelle Touller, Outi Kontkanen,[...]. PLoS One 2012
141
11

The distribution of structural neuropathology in pre-clinical Huntington's disease.
M J Thieben, A J Duggins, C D Good, L Gomes, N Mahant, F Richards, E McCusker, R S J Frackowiak. Brain 2002
209
11

CAG repeat number governs the development rate of pathology in Huntington's disease.
J B Penney, J P Vonsattel, M E MacDonald, J F Gusella, R H Myers. Ann Neurol 1997
466
11

Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.
Kevin Duff, Jane S Paulsen, Leigh J Beglinger, Douglas R Langbehn, Julie C Stout. Biol Psychiatry 2007
262
11

Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.
K P Murphy, R J Carter, L A Lione, L Mangiarini, A Mahal, G P Bates, S B Dunnett, A J Morton. J Neurosci 2000
284
11

White matter connectivity reflects clinical and cognitive status in Huntington's disease.
Govinda R Poudel, Julie C Stout, Juan F Domínguez D, Louisa Salmon, Andrew Churchyard, Phyllis Chua, Nellie Georgiou-Karistianis, Gary F Egan. Neurobiol Dis 2014
62
17

Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis.
Jan Kassubek, Freimut D Juengling, Daniel Ecker, G Bernhard Landwehrmeyer. Cereb Cortex 2005
121
11

Degeneration of the cerebellum in Huntington's disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process.
Udo Rüb, Franziska Hoche, Ewout R Brunt, Helmut Heinsen, Kay Seidel, Domenico Del Turco, Henry L Paulson, Jürgen Bohl, Charlotte von Gall, Jean-Paul Vonsattel,[...]. Brain Pathol 2013
77
12

Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
Liliana B Menalled, Andrea E Kudwa, Sam Miller, Jon Fitzpatrick, Judy Watson-Johnson, Nicole Keating, Melinda Ruiz, Richard Mushlin, William Alosio, Kristi McConnell,[...]. PLoS One 2012
215
10

Neurocognitive signs in prodromal Huntington disease.
Julie C Stout, Jane S Paulsen, Sarah Queller, Andrea C Solomon, Kathryn B Whitlock, J Colin Campbell, Noelle Carlozzi, Kevin Duff, Leigh J Beglinger, Douglas R Langbehn,[...]. Neuropsychology 2011
247
10

Trinucleotide repeat length instability and age of onset in Huntington's disease.
M Duyao, C Ambrose, R Myers, A Novelletto, F Persichetti, M Frontali, S Folstein, C Ross, M Franz, M Abbott. Nat Genet 1993
806
10

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.
Laurent R Gauthier, Bénédicte C Charrin, Maria Borrell-Pagès, Jim P Dompierre, Hélène Rangone, Fabrice P Cordelières, Jan De Mey, Marcy E MacDonald, Volkmar Lessmann, Sandrine Humbert,[...]. Cell 2004
779
10

Brain structure in preclinical Huntington's disease.
Jane S Paulsen, Vince A Magnotta, Ania E Mikos, Henry L Paulson, Elizabeth Penziner, Nancy C Andreasen, Peg C Nopoulos. Biol Psychiatry 2006
172
10

Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.
G Schilling, M W Becher, A H Sharp, H A Jinnah, K Duan, J A Kotzuk, H H Slunt, T Ratovitski, J K Cooper, N A Jenkins,[...]. Hum Mol Genet 1999
578
10


Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease.
Jessica M Simpson, Joana Gil-Mohapel, Mahmoud A Pouladi, Mohamed Ghilan, Yuanyun Xie, Michael R Hayden, Brian R Christie. Neurobiol Dis 2011
78
11


Choosing an animal model for the study of Huntington's disease.
Mahmoud A Pouladi, A Jennifer Morton, Michael R Hayden. Nat Rev Neurosci 2013
203
9

Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes.
J Nasir, S B Floresco, J R O'Kusky, V M Diewert, J M Richman, J Zeisler, A Borowski, J D Marth, A G Phillips, M R Hayden. Cell 1995
586
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.